FDA Drug Application (202298) for GLIPIZIDE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number202298
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage2.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameGLIPIZIDE
Active IngredientGLIPIZIDE

Active IngredientCount
List of drugs with Active Ingredient GLIPIZIDE5


Back to FDA Applications sponsored by MYLAN PHARMS INC